The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis

JAMA

Volumn 276, Issue 15, 1996, Pages 1223-1228

  Pablos Méndez, Ariel ^a,b   Sterling, Timothy R ^b,c   Frieden, Thomas R ^b,d  

^a The New York Presbyterian Hospital   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c USAF Medical Center Keesler   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SPUTUM CULTURE; SURVIVAL; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

EID: 0029846957     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.15.1223     Document Type: Article

References (43)

1. Dolin PJ, Raviglione MC, Kochi A. Estimates of future global tuberculosis morbidity and mortality. MMWR Morb Mortal Wkly Rep. 1993;42:961-964.
2. Ravigiione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995;273: 220-226.
3. Bloch AB, Reider HL, Kelly GD, Cauthen GM, Hayden CH, Snider DE. The epidemiology of tuberculosis in the United States: implications for diagnosis and treatment. Clin Chest Med. 1989;10: 297-313.
4. Jereb JA, Kelly GD, Dooley SW, Cauthen GM, Snider DE. Tuberculosis morbidity in the United States: final data, 1990. MMWR Morb Mortal Wkly Rep. 1992;40(SS-3):23-27.
5. Centers for Disease Control. Tuberculosis in the United States: 1987. Washington, DC: US Government Printing Office; 1989. US Dept of Health and Human Services publication CDC 89-8322.
6. New York City Dept of Health. Tuberculosis in New York City, 1990: Information Survey. New York, NY: New York City Dept of Health; 1991.
7. Mendelson MH, Adler J. Resurgence of tuberculosis: relationship to HIV and implications for infection control. Mt Sinai J Med. 1990;57:221-224.
8. Barnes PF, Barrows SA. Tuberculosis in the 1990s. Ann Intern Med. 1993;119:400-410.
9. Drucker E, Alcabes P, Bosworth W, Sckell B. Childhood tuberculosis in the Bronx, New York. Lancet. 1994;343:1482-1485.
10. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994;272:535-539.
11. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745-749.
12. Frieden TR, Steriing T, Pablos-Méndez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
13. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide Survey of drug-resistant tuberculosis in the United States. JAMA. 1994;271:665-671.
14. Neville K, Bromberg A, Bromberg R, Bonk S, Hanna BA, Rom WN. The third epidemic - multidrug-resistant tuberculosis. Chest. 1994;105:45-48.
15. Stoneburner R, Laroche E, Prevots R, et al. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City: implications for the expansion of the AIDS case definition. Arch Intern Med. 1992;152:2033-2037.
16. Braun MM, Coté TR, Rabkin CS. Trends in death with tuberculosis during the AIDS era. JAMA. 1998;269:2865-2868.
17. Fischl MA, Daikos GL, Uttamchandani RB, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992; 117:184-190.
18. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328: 527-532.
19. WHO Tuberculosis Programme. Framework for Effective Tuberculosis Control. Geneva, Switzerland: World Health Organization; 1994. World Health Organization publication WHO/TB/94.179.
20. Stampfer MJ, Willet WC, Speizer FE. Test of the National Death Index. Am J Epidemiol. 1984; 119:837-839.
21. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6. Atlanta, Ga: Centers for Disease Control and Prevention; 1994.
22. Norusie MJ. SPSS for Windows: Advanced Statistics, Release 6.0. Chicago, Ill: SPSS Inc; 1993.
23. Cox DR. Regression methods and life tables. J R Stat Soc B. 1972;34:187-220.
24. Narain R, Gothi GD, Nair SS, et al. Tuberculosis in a rural population of South India: a five year epidemiologic study. Bull World Health. Organ. 1974; 51:473-488.
25. Centers for Disease Control. Tuberculosis Statistics: States and Cities, 1985. Washington, DC: US Government Printing Office; 1986. US Dept of Health and Human Services publication CDC 87-8249.
26. Centers for Disease Control. National HIV Seroprevalence Surveys: Summary of Results (Through 1989). Washington, DC: US Government Printing Office; 1990. US Dept of Health and Human Services publication HIV/CID/9-90/006.
27. Bureau of Tuberculosis Control. Information Summary 1994. New York, NY: New York City Dept of Health; 1995.
28. Washko RM, O'Doherty J, Frieden TR. Tuberculosis mortality, New York City, 1992. In: Proceedings of the 43rd Annual Epidemic Intelligence Service Conference; April 18-22, 1994; Atlanta, Ga.
29. Ackah AN, Coulibaiy D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet. 1995;345: 607-610.
30. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival Am Rev Respir Dis. 1987; 136:570-574.
31. Shirai T, Sato A, Chida K, et al. A study of causes of death among patients with active pulmonary tubercuiosis from the standpoint of host factors. Kekkaku. 1990;65:397-405.
32. Nunn P, Brindle R, Carpenter L, et al. Cohort study of HIV infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (6-month) mortality. Am, Rev Repair Dis. 1992;146:849-854.
33. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991; 324:289-294;
34. Perriens JH, St Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med. 1995;332:779-784.
35. Alwood K, Keruiy J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS. 1994;8:1103-1108.
36. Mathur P, Sacks L, Auten G, Sall R, Levy C, Gordin F. Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med. 1994; 154:306-310.
37. Rieder HL, Kelly GD, Bloch AB, Cauthen GM, Snider DE Jr. Tuberculosis diagnosed at death in the United States. Chest. 1991;100:678-681.
38. Mitchison DA, Nunn AJ. Influence of initial drug-resistance on the response to short course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986;133:423-430.
39. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994;149: 1359-1374.
40. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA. 1995;274: 945-951.
41. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it. N Engl J Med 1993;328:576-578.
42. Frieden TE, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. N Engl J Med. 1995;333:229-233.
43. Telzak EE, Sepkowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med. 1995;333:907-911.